Literature DB >> 25811241

Phosphorylation and Alternative Splicing of 7B2 Reduce Prohormone Convertase 2 Activation.

Bruno Ramos-Molina1, Iris Lindberg.   

Abstract

FAM20C is a secretory kinase responsible for the phosphorylation of multiple secreted proteins in mammalian cells; it has been shown to phosphorylate serine residues within a variety of different bone proteins. In this work we demonstrate that FAM20C also phosphorylates threonines, specifically those within the N-terminal domain of the neuroendocrine chaperone 7B2. Analysis of the primary sequence of 7B2 revealed that three threonine residues in its N-terminal domain are located within FAM20C consensus motifs: Thr73, Thr99, and Thr111. The individual substitution of Thr73 and Thr111 residues by neutral alanines caused a marked decrease in the total phosphorylation of 7B2. Furthermore, the phosphomimetic substitution of Thr111 by Glu clearly diminished the ability of 7B2 to activate pro-prohormone convertase 2 (PC2) in 7B2-lacking SK-N-MC neuroblastoma cells, suggesting that the phosphorylation of this residue critically impacts the 7B2-proPC2 interaction. However, the phosphomimetic mutation did not alter 7B2's ability to function as an antiaggregant for human islet amyloid polypeptide. FAM20C-mediated phosphorylation of a common alternatively spliced variant of human 7B2 that lacks Ala100 (thus eliminating the Thr99 phosphorylation consensus site) was similar to the Ala-containing protein, but this variant did not activate proPC2 as efficiently as the Ala-containing protein. Although threonines within 7B2 were phosphorylated efficiently, FAM20C was incapable of performing the well-known regulatory threonine phosphorylation of the molecular chaperone binding immunoglobulin protein. Taken together, these results indicate that FAM20C plays a role in 7B2-mediated proPC2 activation by phosphorylating residue Thr111; and that 7B2 function is regulated by alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811241      PMCID: PMC4415208          DOI: 10.1210/me.2014-1394

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  48 in total

1.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.

Authors:  A Bertolotti; Y Zhang; L M Hendershot; H P Harding; D Ron
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

Review 2.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Evidence for the phosphorylation of a proenkephalin-derived peptide, peptide B.

Authors:  N B D'Souza; I Lindberg
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

4.  The isolation and chemical characterization of phosphorylated enkephalin-containing peptides from bovine adrenal medulla.

Authors:  A Watkinson; J Young; A Varro; G J Dockray
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

5.  The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase.

Authors:  L Paquet; F Bergeron; A Boudreault; N G Seidah; M Chrétien; M Mbikay; C Lazure
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

6.  Biosynthesis of phosphorylated forms of corticotropin-related peptides.

Authors:  H P Bennett; C A Browne; S Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  The consensus sequences for cdc2 kinase and for casein kinase-2 are mutually incompatible. A study with peptides derived from the beta-subunit of casein kinase-2.

Authors:  O Marin; F Meggio; G Draetta; L A Pinna
Journal:  FEBS Lett       Date:  1992-04-13       Impact factor: 4.124

8.  The production by alternate splicing of two mRNAs differing by one codon could be an intrinsic property of neuroendocrine protein 7B2 gene expression in man.

Authors:  L Paquet; C Lazure; N G Seidah; M Chrétien; M Mbikay
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

9.  Identity of the immunoglobulin heavy-chain-binding protein with the 78,000-dalton glucose-regulated protein and the role of posttranslational modifications in its binding function.

Authors:  L M Hendershot; J Ting; A S Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

10.  Interconversion of three differentially modified and assembled forms of BiP.

Authors:  P J Freiden; J R Gaut; L M Hendershot
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more
  5 in total

1.  Family with sequence similarity member 20C is the primary but not the only kinase for the small-integrin-binding ligand N-linked glycoproteins in bone.

Authors:  Xiudong Yang; Wenjuan Yan; Ye Tian; Pan Ma; Lynne A Opperman; Xiaofang Wang
Journal:  FASEB J       Date:  2015-08-31       Impact factor: 5.191

2.  Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.

Authors:  Hiroyuki Yamamoto; Bruno Ramos-Molina; Adam N Lick; Matthew Prideaux; Valeria Albornoz; Lynda Bonewald; Iris Lindberg
Journal:  Bone       Date:  2015-12-31       Impact factor: 4.398

3.  Proteolytic processing of secretory pathway kinase Fam20C by site-1 protease promotes biomineralization.

Authors:  Xinxin Chen; Jianchao Zhang; Pulan Liu; Yangyang Wei; Xi'e Wang; Junyu Xiao; Chih-Chen Wang; Lei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 11.205

Review 4.  The ABCs of the atypical Fam20 secretory pathway kinases.

Authors:  Carolyn A Worby; Joshua E Mayfield; Adam J Pollak; Jack E Dixon; Sourav Banerjee
Journal:  J Biol Chem       Date:  2021-01-08       Impact factor: 5.157

5.  Divergent kinase regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole.

Authors:  Tsebaot Beraki; Xiaoyu Hu; Malgorzata Broncel; Joanna C Young; William J O'Shaughnessy; Dominika Borek; Moritz Treeck; Michael L Reese
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.